Russia Prepares $10 COVID-19 Vaccine For International Launch
Aims To Compete With Pfizer On Efficacy, Undercut On Price
Executive Summary
Russia is promising the best of both worlds – a low price with a near-perfect efficacy. While the basic science is plausible, its best-in-class claims are bound to generate skepticism.
You may also be interested in...
Ex-US FDA Official Petitions Agency To Stop Reviewing Applications From Russian Companies Amid War In Ukraine
The request could drag the agency back into a political arena it has been trying to avoid.
How COVID-19 Defined 2020 For Biopharma
Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.
The Race To Develop A COVID-19 Vaccine: mRNA Pioneers Lead The Way
Our updated graphic tracker of key developments from the leading vaccine candidates.